BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27996211)

  • 1. GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia.
    Wang JR; Sun PH; Ren ZX; Meltzer HY; Zhen XC
    CNS Neurosci Ther; 2017 Feb; 23(2):174-187. PubMed ID: 27996211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Glycogen Synthase Kinase-3β in D
    Li YC; Panikker P; Xing B; Yang SS; Alexandropoulos C; McEachern EP; Akumuo R; Zhao E; Gulchina Y; Pletnikov MV; Urs NM; Caron MG; Elefant F; Gao WJ
    Biol Psychiatry; 2020 Apr; 87(8):745-755. PubMed ID: 31892408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 7 nicotinic receptor agonist and positive allosteric modulators improved social and molecular deficits of MK-801 model of schizophrenia in rats.
    Unal G; Bekci H; Cumaoglu A; Yerer MB; Aricioglu F
    Pharmacol Biochem Behav; 2020 Jun; 193():172916. PubMed ID: 32220620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.
    Li YC; Xi D; Roman J; Huang YQ; Gao WJ
    J Neurosci; 2009 Dec; 29(49):15551-63. PubMed ID: 20007479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons.
    Rotaru DC; Lewis DA; Gonzalez-Burgos G
    J Physiol; 2007 Jun; 581(Pt 3):981-1000. PubMed ID: 17395630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
    Sarantis K; Matsokis N; Angelatou F
    Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels.
    Gamo NJ; Lur G; Higley MJ; Wang M; Paspalas CD; Vijayraghavan S; Yang Y; Ramos BP; Peng K; Kata A; Boven L; Lin F; Roman L; Lee D; Arnsten AF
    Biol Psychiatry; 2015 Dec; 78(12):860-70. PubMed ID: 25731884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3β inhibitors reverse cocaine-induced synaptic transmission dysfunction in the nucleus accumbens.
    Zhao R; Chen J; Ren Z; Shen H; Zhen X
    Synapse; 2016 Nov; 70(11):461-70. PubMed ID: 27377051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
    Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
    Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
    Scornaiencki R; Cantrup R; Rushlow WJ; Rajakumar N
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1195-208. PubMed ID: 19275776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress reduces renal dopamine D1 receptor-Gq/11alpha G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2.
    Banday AA; Lokhandwala MF
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F306-15. PubMed ID: 17459951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3beta in the nucleus accumbens core mediates cocaine-induced behavioral sensitization.
    Xu CM; Wang J; Wu P; Zhu WL; Li QQ; Xue YX; Zhai HF; Shi J; Lu L
    J Neurochem; 2009 Dec; 111(6):1357-68. PubMed ID: 19799712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSK-3β downregulates Nrf2 in cultured cortical neurons and in a rat model of cerebral ischemia-reperfusion.
    Chen X; Liu Y; Zhu J; Lei S; Dong Y; Li L; Jiang B; Tan L; Wu J; Yu S; Zhao Y
    Sci Rep; 2016 Feb; 6():20196. PubMed ID: 26838164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action.
    Yu Y; Wang JR; Sun PH; Guo Y; Zhang ZJ; Jin GZ; Zhen X
    J Neurochem; 2008 Feb; 104(4):946-56. PubMed ID: 18005341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport.
    Gildea JJ; Shah IT; Van Sciver RE; Israel JA; Enzensperger C; McGrath HE; Jose PA; Felder RA
    Kidney Int; 2014 Jul; 86(1):118-26. PubMed ID: 24552847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical dopamine D5 receptors regulate neuronal circuit oscillatory activity and memory in rats.
    Albeely AM; Nolan CJ; Rasmussen DJ; Bailey CDC; Perreault ML
    CNS Neurosci Ther; 2023 Sep; 29(9):2469-2480. PubMed ID: 37076975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization.
    Fiorentini C; Busi C; Gorruso E; Gotti C; Spano P; Missale C
    Mol Pharmacol; 2008 Jul; 74(1):59-69. PubMed ID: 18424554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective dopamine D
    Nesbit MO; Chai A; Axerio-Cilies P; Phillips AG; Wang YT; Held K
    Neuropharmacology; 2022 Apr; 207():108967. PubMed ID: 35077763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.